Onduo is on a mission to make "healthy" easy Onduo, a Verily subsidiary, announced today that the company is building on the...
Research Goes Red: How feeling & emotions differ by age and through the experience of the COVID-19 pandemic
Baseline Sleep Mission results Over 1,000 Baseline Health Study volunteers contributed 12,269 nights of sleep data to...
How COVID-19 Research Project members are connecting with friends and family Our latest survey of over 17,000 participants in the COVID-19 Research Project...
Singapore Prime Minister Lee Hsien Loong visits Verily’s mosquito sex sorting operations at the Environmental Health Institute
Waymo: Providing COVID-19 testing to our team in partnership with Verily The health and safety of our team is our top priority as we continue to navigate the...
Verily stands up CLIA-certified lab focused on COVID-19 testing An interview with Deb Hanks, MD, Verily’s head of Pathology
A Look At The COVID-19 Research Community More than 31,000 members across 49 states joined the COVID-19 Research Project in the...
Verily Expands Baseline COVID-19 Testing Program to 130 Locations Nationwide, Providing Over 256,844 Tests
New Baseline COVID-19 Research Project launches Advancing scientific understanding of virus, with initial focus on antibody testing
Verily collaborates with CA Governor's office, federal and local public health authorities on COVID-19
Verily Study Watch AFib clearance Verily receives FDA 510(k) clearance for Study Watch with Irregular Pulse Monitor
Better data, better care By finding new ways to collect, organize and activate data, we can have a meaningful...
Onduo and scaling the virtual care model Growing the virtual care model across the spectrum of health.
A new way to see disease Learn about our end-to-end platform for mapping the molecular geography of tissue biopsies.
Verily Advisory Board Series: Dennis Ausiello on Understanding Wellness and its Progression to Disease
Redesigning participant onboarding to put the user first Reimagining the participant experience for people with type 2 diabetes.
DeepMass: A new machine learning method for the characterization of proteins Exploring one of the first applications of deep learning to the field of mass spectrometry.
Going big with nanoparticle technology in coronary artery disease Engineering drug delivery with nanoparticle technology in coronary artery disease
Question convention responsibly: how Verily is tackling data and privacy Meaningful use of data in healthcare, and the precautions that come with it
Capturing health information with Study Watch Launching an investigational device to capture health info for clinical research
Seeing the future of ocular devices Developing smart ocular devices with Alcon to help improve everyday health routines
A brand new approach to heart health Working with the American Heart Association & Astrazeneca to reverse coronary heart disease.
Mapping the immune system Using advanced computational analysis to generate detailed immune system profiles.
Tracking Parkinson’s Disease A multi-year study to explore the factors that impact the course of Parkinson's disease.
Giving back through Verily Serve Verily Serve is a week-long annual volunteering event centered around giving back
